Results
|
|
21.
|
|
|
|
22.
|
|
|
|
23.
|
|
|
|
24.
|
|
|
|
25.
|
|
|
|
26.
|
|
|
|
27.
|
|
|
|
28.
|
|
|
|
29.
|
|
|
|
30.
|
|
|
|
31.
|
|
|
|
32.
|
|
|
|
33.
|
|
|
|
34.
|
|
|
|
35.
|
|
|
|
36.
|
Supplementary statements by some members of the board of directors. [electronic resource] by
- Glass, H B
- Hoagland, H
- Holton, G
- Klopsteg, P E
- Price, D K
- Rees, M S
- Rieser, L M
- Roberts, W O
- Steinbach, H B
- Wolfle, D
Producer: 20100702
In:
Science (New York, N.Y.) vol. 161
Availability: No items available.
|
|
|
37.
|
A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform. [electronic resource] by
- Deeken, J F
- Cormier, T
- Price, D K
- Sissung, T M
- Steinberg, S M
- Tran, K
- Liewehr, D J
- Dahut, W L
- Miao, X
- Figg, W D
Producer: 20100823
In:
The pharmacogenomics journal vol. 10
Availability: No items available.
|